Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Central Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06458712
What this trial is testing

Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies

Who this might be right for
Advanced Cancers (Breast, Ovarian, mCRPC, Pancreatic Ductal Adenocarcinoma (PDAC), Brain Mets) With Specific Mutations (Homologous Recombination Deficiency)
Duke Street Bio Ltd 180
Large-scale testing (Phase 3)Looking for participantsNCT05717803
What this trial is testing

Segmentectomy for Ground Glass-dominant Invasive Lung Cancer (ECTOP-1012)

Who this might be right for
SegmentectomyLung Adenocarcinoma
Fudan University 307
Not applicableStudy completedNCT03297788
What this trial is testing

Whole Brain Radiation Therapy Alone vs. Radiosurgery for SCLC Patients With 1-10 Brain Metastases

Who this might be right for
SCLCBrain Metastases
Juergen Debus 56
Testing effectiveness (Phase 2)Ended earlyNCT04914897
What this trial is testing

SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma (Pegathor Lung 202)

Who this might be right for
Pleural MesotheliomaNon-small Cell Lung Cancer
Sanofi 106
Testing effectiveness (Phase 2)WithdrawnNCT05338580
What this trial is testing

Clinical Trial of TJ271 Injection Combined With Pembrolizumab in the Treatment of Advanced Solid Tumors

Who this might be right for
First-line Non-small-cell Lung CancerFirst-line Urothelial CarcinomaSecond-line Urothelial Carcinoma+1 more
TJ Biopharma Co., Ltd.
Not applicableStudy completedNCT00453661
What this trial is testing

Cancer Prevention and Treatment Demonstration for Ethnic and Racial Minorities

Who this might be right for
Breast CancerCervical CancerProstate Cancer+2 more
M.D. Anderson Cancer Center 2,472
Post-approval studies (Phase 4)Study completedNCT01373983
What this trial is testing

Intrathecal Bolus Doses of Ziconotide

Who this might be right for
Peripheral Neuropathy
University Hospital, Linkoeping 26
Testing effectiveness (Phase 2)Study completedNCT02085070
What this trial is testing

MK-3475 in Melanoma and NSCLC Patients With Brain Metastases

Who this might be right for
MelanomaNon-Small Cell Lung CancerBrain Metastases
Yale University 65
Not applicableUnknownNCT03427541
What this trial is testing

Explore Prognoses of NSCLC Patients Complicated With Oligometastases

Who this might be right for
Non Small Cell Lung Cancer
Tang-Du Hospital 1,000
Not applicableLooking for participantsNCT07563205
What this trial is testing

Observational Multicenter Study in Patients Receiving Chemotherapy and Amivantamab for Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerNon Small Cell Lung Cancer MetastaticNon Small Cell Lung Cancer NSCLC+6 more
GFPC Investigation 100
Early research (Phase 1)Active Not RecruitingNCT04897022
What this trial is testing

Pembrolizumab and Radiation Therapy in People With Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Memorial Sloan Kettering Cancer Center 7
Testing effectiveness (Phase 2)Study completedNCT00070629
What this trial is testing

CPG 7909 Injection in Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell Lung
Pfizer 116
Not applicableUnknownNCT04377802
What this trial is testing

Safe Return to Regular Clinical Operation After COVID-19 Pandemic

Who this might be right for
COVID 19
King Fahad Specialist Hospital Dammam 400
Testing effectiveness (Phase 2)UnknownNCT06195683
What this trial is testing

Serplulimab for Patients With Non-small Cell Lung Cancer (NSCLC) With TPS ≥ 50%: a Prospective, Single-center, Single-arm Phase 2 Study.

Who this might be right for
Non-small Cell Lung CancerPDL1 Gene Mutation
Zhejiang Cancer Hospital 23
Early research (Phase 1)Study completedNCT02890069
What this trial is testing

PDR001 in Combination With LCL161, Everolimus or Panobinostat

Who this might be right for
Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma
Novartis Pharmaceuticals 298
Testing effectiveness (Phase 2)UnknownNCT04056572
What this trial is testing

Study of TQ-B3139 in Subjects With Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) Previously Treated With Crizotinib

Who this might be right for
ALK-positive NSCLC
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 135
Testing effectiveness (Phase 2)UnknownNCT03544723
What this trial is testing

Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.

Who this might be right for
Solid TumorLymphoma
MultiVir, Inc. 40
Early research (Phase 1)Not Yet RecruitingNCT07550842
What this trial is testing

A Clinical Study for the Safety and Efficacy of BL0020 Injection in Combination With Toripalimab Injection in Patients With Recurrent Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Carcinoma of Lung
Shanghai Best-Link Bioscience, LLC 33
Early research (Phase 1)UnknownNCT05573373
What this trial is testing

Pamiparib (BGB-290) Was Used in EGFR-TkIs Resistant Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell LungEGF-R Positive Non-Small Cell Lung Cancer
Affiliated Hospital of Jiangnan University 40
Testing effectiveness (Phase 2)UnknownNCT04833205
What this trial is testing

Clinical Efficacy and Safety of EGFR-TKI Combined With Nimotuzumab in the Treatment of Leptomeningeal Metastases From Lung Cancer

Who this might be right for
Leptomeningeal MetastasisLung Cancer
Hui Bu 30
Next Page